Fig. 3.
The effects of COVID-19 on pancreatic β-cells have been studied. SARS-COV-2 causes the downregulation of ACE-2, which is located over β-cells, increasing cytokine storm and fibrosis of the pancreas, as well as a reduction in pancreatic blood flow and insulin secretion, all of which contribute to decreased pancreas survival and severity of disease progression in the patient. ACE2, Angiotensin-converting enzyme 2; Ang 1–7, Angiotensin 1–7; AT1R, Angiotensin II receptor type 1; SARS-COV-2, severe acute respiratory syndrome corona virus-2.